换一批
换一批CSCO guidelines for colorectal cancer version 2024:Updates and discussions
摘要：
According to the latest global cancer statistics,colorectal cancer(CRC)is the most common malignancy of the digestive system and the second most lethal among all cancer types(1).In China,CRC is the second most prevalent cancer,following only after lung cancer(2).The first version of the Chinese Society of Clinical Oncology(CSCO)guideline was launched in 2017 and has been updated annually based on the latest findings of clinical research,drug accessibility and expert consensus(3-8).Here,we present the main updates of the 2024 version compared to the 2023 version.
更多
作者：
作者单位：
Department of Medical Oncology(Key Laboratory of Cancer Prevention and Intervention,China National Ministry of Education,Key Laboratory of Molecular Biology in Medical Sciences,Zhejiang Province,China),the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,China
[1]
Department of Medical Oncology(Key Laboratory of Cancer Prevention and Intervention,China National Ministry of Education,Key Laboratory of Molecular Biology in Medical Sciences,Zhejiang Province,China),the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,China;Zhejiang Provincial Clinical Research Center for CANCER,Hangzhou 310009,China;Cancer Center,Zhejiang University,Hangzhou 310058,China
[2]
期刊：
《中国癌症研究（英文版）》2024年36卷3期 233-239页
SCIMEDLINEISTICCSCD
栏目名称：
Guidelines
DOI：
10.21147/j.issn.1000-9604.2024.03.01
发布时间：
2024-08-06
- 翻译满意度评价：
- 提交
- 浏览：3
- 被引：0
- 下载：3
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
